D.F. presented with Hepatitis C and prostate cancer (PSA 14.2, Gleason 6). He was diagnosed with moderately differentiated adenocarcinoma with high heterogeneity, when he experienced hematuria 11/97. Hepatitis C was first treated in 1994 with acupuncture and homeopathy with resolution of increased liver enzymes.
The patient was treated with total androgen blockage (TAB) starting in 5/98 to stabilize the prostate cancer - his PSA decreased to 4.9. The last Lupron was administered 1/99 and the last Casodex was taken 2/99. Measurement 12/98 of Hepatitis C Virus RNA by PCR testing was 2,498,200. D.F. began AHCC 1/99. 2/99 AHCC was increased to 6 gms per day in divided doses. Follow-up testing done 7/99 showed a significant decrease in the level of Hepatitis C Virus RNA to 499,600 (an 80% reduction in 6 months).
The patient was treated with total androgen blockage (TAB) starting in 5/98 to stabilize the prostate cancer - his PSA decreased to 4.9. The last Lupron was administered 1/99 and the last Casodex was taken 2/99. Measurement 12/98 of Hepatitis C Virus RNA by PCR testing was 2,498,200. D.F. began AHCC 1/99. 2/99 AHCC was increased to 6 gms per day in divided doses. Follow-up testing done 7/99 showed a significant decrease in the level of Hepatitis C Virus RNA to 499,600 (an 80% reduction in 6 months).
- Joel S. Edman, D.Sc. and Dr. Fred Pescatore, M.D.
